Navigation Links
Vascular Surgeons Agree: Case Rehearsal Improves Outcomes
Date:11/12/2008

CLEVELAND, Ohio and LOD, Israel, November 12 /PRNewswire/ -- Surgeons at the University of Rochester Medical Center, NY indicated that patient-specific CTA data can be converted to an endovascular simulator (ANGIO Mentor(TM), Simbionix US) with high face validity. The surgeons "strongly agreed" that the simulation improved the operative flow, increased patient safety and efficiency of instrument use, decreased overall operative and fluoroscopy time and the amount of contrast used, and that the operative and simulator outcomes were similar.

An abstract of the study is provided below:

Patient Specific Case Rehearsals Using an Endovascular Simulator Prior to Carotid Artery Stenting

Sean J Hislop, MD, Joseph H Hedrick, MD, Michael J Singh, MD, Jeffrey M Rhodes, MD, Joseph P Hart, MD, Marcia Johansson, ACNP, and Karl A Illig, MD

Division of Vascular Surgery, at the Strong Heart and Vascular Center, University of Rochester Medical Center, NY

Objectives: To determine whether a patient's specific carotid anatomy can be modeled using CTA on an endovascular simulator and whether preoperative patient-specific case rehearsal accurately predicts operative experience.

Methods: Patients underwent CTA of the arch and carotid circulation. Simbionix (Cleveland, OH and Lod, Israel) used deidentified CTAs to create simulation files (using PROcedure(TM) Rehersal Studio). The surgeon performed the simulated case within 24 hours of the actual procedure. Likert surveys (strongly agree - strongly disagree) were completed assessing face validity, or the degree to which the simulation mimicked real life.

Results: Five patient-specific simulations were performed. The surgeons "strongly agreed" (median score 5/5) that the simulation improved the operative flow, increased patient safety and efficiency of instrument use, assisted in selection of EPD, stent, diagnostic catheter and balloon, decreased overall operative and fluoroscopy time and the amount of contrast used, and that the operative and simulator outcomes were similar. They "agreed" (median score 4/5) that the simulation assisted with vessel access and with wire selection. Face validity was excellent: surgeons "strongly agreed" that the simulator was easy to use, realistically replicated reality, produced realistic imaging and tactile feedback (haptics), realistically replicated patient arch, carotid and lesion anatomy and that it accurately predicted stent dimensions. All simulated EPD, stent, and balloon dimensions matched those used in the operating room. Subjective observations suggested that the simulation predicted difficulty with vessel cannulation but did not accurately model post-stent deployment changes in bifurcation angulation.

Conclusions: These data indicate that patient-specific CTA-derived data can be converted to an endovascular simulator with high face validity. We suggest that case rehearsal prior to an operation may be useful in the planning and execution of carotid artery intervention.

Contact:

Inbal Mazor

VP Marketing

Simbionix

mailto: inbal@simbionix.com

http://www.simbionix.com

Tel: +1-216-229-2040


'/>"/>
SOURCE Simbionix Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. VIA Pharmaceuticals Announces Positive Results of Phase 2 Studies of VIA-2291 in Patients With Serious Cardiovascular Disease
2. Physicians Health Study II Finds No Magic Bullet for Preventing Cardiovascular Disease
3. Atrial Fibrillation Found to be Common in Patients With Atherothrombosis, Increases Risk of Cardiovascular Death, Heart Attack and Stroke
4. Tackling Atrial Fibrillation and Associated Cardiovascular Risk
5. XTENT Announces Clinical Trial Data to be Presented at Annual Meeting of Transcatheter Cardiovascular Therapeutics Next Week
6. Athera Biotechnologies and Dyax Announce a Collaboration to Discover and Develop Antibodies for Cardiovascular Inflammation
7. Data Confirm Synvista Therapeutics Haptoglobin Diagnostic Test Kit Success in Rapidly Determining Cardiovascular Risk in Patients with Diabetes
8. Clinical Trial Shows Cardiovascular Benefits of Rooibos, Popular Antioxidant Herbal Tea from South Africa
9. Prasugrel Head-to-Head Study Showed Reduced Cardiovascular Events in Diabetes Patients by 30 Percent Compared with Clopidogrel
10. Head-to-Head Study Showed Prasugrel Statistically Superior to Clopidogrel in Reducing Recurrent Cardiovascular Events
11. ViaViente Demonstrates Cardiovascular Benefits in New Human Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2017)... , July 28, 2017 EnvoyHealth, a Diplomat company, ... a program for CleverCap LITE, a technology designed to ... to deliver innovative health technology solutions and services that ... CleverCap LITE offers medication monitoring ... bottle cover: Records ...
(Date:7/27/2017)... -- West Pharmaceutical Services, Inc. (NYSE: WST ) ... and updated financial guidance for the full-year 2017. ... Reported net sales of $397.6 million, a ... sales at constant currency (organic) grew by 3.9%. ... to $0.60 in the prior-year quarter. Second-quarter 2017 adjusted ...
(Date:7/26/2017)... Aesthetics, a leading medical aesthetic clinic in Singapore ... skin conditions from the inside. The natural process of ... skin becomes more transparent due to the thinning of the epidermis. Over ... the sun contributes to aging skin, causing age spots and other ... ...
Breaking Medicine Technology:
(Date:8/18/2017)... ... August 18, 2017 , ... Hernandez Insurance Agencies, ... communities throughout the greater DC region, is inaugurating a “New Leash On Life” ... animals and training them to be companions for veterans in need. , The ...
(Date:8/18/2017)... ... 18, 2017 , ... Moore Insurance, a Houston area agency ... is launching a regional charity effort to provide publicity assistance and generate donations ... Tumor Foundation (PBTF) has raised nearly $30 million in donations that has been ...
(Date:8/18/2017)... ... August 18, 2017 , ... The Brian Gifford Agency, an Indiana-based firm providing ... support of Campagna Academy in a charity drive to provide for at-risk children and ... Indiana,” Campagna Academy is a nonprofit organization that has offered critical programs to at-risk ...
(Date:8/18/2017)... ... August 18, 2017 , ... The Golseth Agency, a Texas based insurance ... is spearheading a regional charity campaign organized to provide support to Christina Upchurch and ... this year, Christina and her children returned from out of town to find her ...
(Date:8/18/2017)... (PRWEB) , ... August 18, 2017 , ... ... of highly trained practitioners specializing in bioidentical hormone replacement therapy and integrative medicine, ... hormone imbalance and conditions of aging, such as menopause, andropause, thyroid disorder and ...
Breaking Medicine News(10 mins):